688105 fundamentals
An in-depth look to NANJING VAZYME BIOTECH operating, investing, and financing activities
688105 free cash flow for Q3 24 is -47.11 M CNY. For 2023, 688105 free cash flow was -34.5 M CNY and operating cash flow was 198.4 M CNY.
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM